Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 2002;95(Suppl 41):22–26.

Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.

P A Lambert 1
PMCID: PMC1308633  PMID: 12216271

Full Text

The Full Text of this article is available as a PDF (181.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akasaka T., Tanaka M., Yamaguchi A., Sato K. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother. 2001 Aug;45(8):2263–2268. doi: 10.1128/AAC.45.8.2263-2268.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brinkman F. S., Bains M., Hancock R. E. The amino terminus of Pseudomonas aeruginosa outer membrane protein OprF forms channels in lipid bilayer membranes: correlation with a three-dimensional model. J Bacteriol. 2000 Sep;182(18):5251–5255. doi: 10.1128/jb.182.18.5251-5255.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chaïbi E. B., Sirot D., Paul G., Labia R. Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother. 1999 Apr;43(4):447–458. doi: 10.1093/jac/43.4.447. [DOI] [PubMed] [Google Scholar]
  4. Ciofu O., Fussing V., Bagge N., Koch C., Høiby N. Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting. J Antimicrob Chemother. 2001 Sep;48(3):391–396. doi: 10.1093/jac/48.3.391. [DOI] [PubMed] [Google Scholar]
  5. Gilleland L. B., Gilleland H. E., Gibson J. A., Champlin F. R. Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. J Med Microbiol. 1989 May;29(1):41–50. doi: 10.1099/00222615-29-1-41. [DOI] [PubMed] [Google Scholar]
  6. Giwercman B., Lambert P. A., Rosdahl V. T., Shand G. H., Høiby N. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains. J Antimicrob Chemother. 1990 Aug;26(2):247–259. doi: 10.1093/jac/26.2.247. [DOI] [PubMed] [Google Scholar]
  7. Giwercman B., Meyer C., Lambert P. A., Reinert C., Høiby N. High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment. Antimicrob Agents Chemother. 1992 Jan;36(1):71–76. doi: 10.1128/aac.36.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hancock R. E. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis. 1998 Aug;27 (Suppl 1):S93–S99. doi: 10.1086/514909. [DOI] [PubMed] [Google Scholar]
  9. Henwood C. J., Livermore D. M., James D., Warner M., Pseudomonas Study Group Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test. J Antimicrob Chemother. 2001 Jun;47(6):789–799. doi: 10.1093/jac/47.6.789. [DOI] [PubMed] [Google Scholar]
  10. Livermore D. M. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother. 2001 Mar;47(3):247–250. doi: 10.1093/jac/47.3.247. [DOI] [PubMed] [Google Scholar]
  11. MacLeod D. L., Nelson L. E., Shawar R. M., Lin B. B., Lockwood L. G., Dirk J. E., Miller G. H., Burns J. L., Garber R. L. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J Infect Dis. 2000 Mar;181(3):1180–1184. doi: 10.1086/315312. [DOI] [PubMed] [Google Scholar]
  12. Mah T. F., O'Toole G. A. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001 Jan;9(1):34–39. doi: 10.1016/s0966-842x(00)01913-2. [DOI] [PubMed] [Google Scholar]
  13. Maiti S. N., Phillips O. A., Micetich R. G., Livermore D. M. Beta-lactamase inhibitors: agents to overcome bacterial resistance. Curr Med Chem. 1998 Dec;5(6):441–456. [PubMed] [Google Scholar]
  14. Nichols W. W., Dorrington S. M., Slack M. P., Walmsley H. L. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob Agents Chemother. 1988 Apr;32(4):518–523. doi: 10.1128/aac.32.4.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nikaido H. Multiple antibiotic resistance and efflux. Curr Opin Microbiol. 1998 Oct;1(5):516–523. doi: 10.1016/s1369-5274(98)80083-0. [DOI] [PubMed] [Google Scholar]
  16. Poole K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol. 2001 Apr;3(2):255–264. [PubMed] [Google Scholar]
  17. Riedel K., Hentzer M., Geisenberger O., Huber B., Steidle A., Wu H., Høiby N., Givskov M., Molin S., Eberl L. N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology. 2001 Dec;147(Pt 12):3249–3262. doi: 10.1099/00221287-147-12-3249. [DOI] [PubMed] [Google Scholar]
  18. Srikumar R., Tsang E., Poole K. Contribution of the MexAB-OprM multidrug efflux system to the beta-lactam resistance of penicillin-binding protein and beta-lactamase-derepressed mutants of Pseudomonas aeruginosa. J Antimicrob Chemother. 1999 Oct;44(4):537–540. doi: 10.1093/jac/44.4.537. [DOI] [PubMed] [Google Scholar]
  19. Stewart P. S., Costerton J. W. Antibiotic resistance of bacteria in biofilms. Lancet. 2001 Jul 14;358(9276):135–138. doi: 10.1016/s0140-6736(01)05321-1. [DOI] [PubMed] [Google Scholar]
  20. Vahaboglu H., Coskunkan F., Tansel O., Ozturk R., Sahin N., Koksal I., Kocazeybek B., Tatman-Otkun M., Leblebicioglu H., Ozinel M. A. Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J Med Microbiol. 2001 Jul;50(7):642–645. doi: 10.1099/0022-1317-50-7-642. [DOI] [PubMed] [Google Scholar]
  21. Woodford N., Palepou M. F., Babini G. S., Bates J., Livermore D. M. Carbapenemase-producing Pseudomonas aeruginosa in UK. Lancet. 1998 Aug 15;352(9127):546–547. doi: 10.1016/s0140-6736(05)79255-2. [DOI] [PubMed] [Google Scholar]
  22. Ziha-Zarifi I., Llanes C., Köhler T., Pechere J. C., Plesiat P. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob Agents Chemother. 1999 Feb;43(2):287–291. doi: 10.1128/aac.43.2.287. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES